OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stock Position in Teleflex Incorporated (NYSE:TFX)

OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 82.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,593 shares of the medical technology company's stock after acquiring an additional 5,250 shares during the quarter. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in Teleflex were worth $2,063,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. Barclays PLC lifted its stake in shares of Teleflex by 1.6% during the 3rd quarter. Barclays PLC now owns 89,907 shares of the medical technology company's stock valued at $22,233,000 after buying an additional 1,426 shares in the last quarter. Franklin Resources Inc. lifted its stake in shares of Teleflex by 64.3% during the 3rd quarter. Franklin Resources Inc. now owns 9,683 shares of the medical technology company's stock valued at $2,298,000 after buying an additional 3,790 shares in the last quarter. Principal Financial Group Inc. lifted its stake in shares of Teleflex by 2.7% during the 3rd quarter. Principal Financial Group Inc. now owns 80,409 shares of the medical technology company's stock valued at $19,887,000 after buying an additional 2,086 shares in the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Teleflex by 4.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,305 shares of the medical technology company's stock valued at $588,000 after buying an additional 128 shares in the last quarter. Finally, Czech National Bank lifted its stake in shares of Teleflex by 4.9% during the 4th quarter. Czech National Bank now owns 10,070 shares of the medical technology company's stock valued at $1,792,000 after buying an additional 472 shares in the last quarter. Institutional investors own 95.62% of the company's stock.

Teleflex Stock Up 2.1%

TFX traded up $2.66 during trading on Friday, hitting $129.15. The stock had a trading volume of 542,769 shares, compared to its average volume of 638,696. The stock has a 50 day simple moving average of $132.83 and a two-hundred day simple moving average of $162.64. The company has a market capitalization of $5.71 billion, a PE ratio of 25.67, a PEG ratio of 1.73 and a beta of 1.17. Teleflex Incorporated has a twelve month low of $120.06 and a twelve month high of $249.91. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.88 by $0.03. The business had revenue of $700.67 million during the quarter, compared to analysts' expectations of $699.37 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business's quarterly revenue was down 5.0% on a year-over-year basis. During the same quarter last year, the company posted $3.21 earnings per share. On average, research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Tuesday, May 20th will be issued a dividend of $0.34 per share. The ex-dividend date is Tuesday, May 20th. This represents a $1.36 annualized dividend and a dividend yield of 1.05%. Teleflex's dividend payout ratio (DPR) is presently 42.90%.

Wall Street Analysts Forecast Growth

Several analysts have commented on TFX shares. Piper Sandler reiterated a "neutral" rating and issued a $140.00 price target (down previously from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Morgan Stanley decreased their target price on shares of Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research report on Monday, May 5th. Wells Fargo & Company decreased their target price on shares of Teleflex from $146.00 to $137.00 and set an "equal weight" rating on the stock in a research report on Friday, May 2nd. Royal Bank of Canada decreased their target price on shares of Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a research report on Friday, May 2nd. Finally, Raymond James cut shares of Teleflex from an "outperform" rating to a "market perform" rating in a research report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $164.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.